Carriage of HLA-DRB1*11 and 1*12 alleles and risk factors in patients with breast cancer in Burkina Faso

Several factors contribute to the development of breast cancer, including the immune system. This study is aimed to characterize the carriage of human leukocyte antigen (HLA)-DRB1*11 and 1*12 alleles in patients with breast cancer. This case-control study consisted of 96 histologically diagnosed bre...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Zouré Abdou Azaque, Amegnona Lanyo Jospin, Zongo Nayi, Kiendrebeogo Isabelle Touwendpoulimdé, Sorgho Pegdwendé Abel, Zongo Fabienne Ingrid, Yonli Albert Théophane, Sombié Herman Karim, Bambara Aboubacar Hierrhum, Sawadogo Alexis Yobi, Ouedraogo Marie N. L., Traoré Lassina, Zongo Sidnooma Véronique, Lallogo Doriane Tatiana, Bazié Bapio Valery Jean Télesphore Elvira, Zohoncon Théodora M., Dijgma Florencia W., Simpore Jacques
Formato: article
Lenguaje:EN
Publicado: De Gruyter 2021
Materias:
Acceso en línea:https://doaj.org/article/7114d3260cc844129f4e9785dec6afb8
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:7114d3260cc844129f4e9785dec6afb8
record_format dspace
spelling oai:doaj.org-article:7114d3260cc844129f4e9785dec6afb82021-12-05T14:10:42ZCarriage of HLA-DRB1*11 and 1*12 alleles and risk factors in patients with breast cancer in Burkina Faso2391-541210.1515/biol-2021-0113https://doaj.org/article/7114d3260cc844129f4e9785dec6afb82021-10-01T00:00:00Zhttps://doi.org/10.1515/biol-2021-0113https://doaj.org/toc/2391-5412Several factors contribute to the development of breast cancer, including the immune system. This study is aimed to characterize the carriage of human leukocyte antigen (HLA)-DRB1*11 and 1*12 alleles in patients with breast cancer. This case-control study consisted of 96 histologically diagnosed breast cancer cases and 102 controls (cases without breast abnormalities). A multiplex polymerase chain reaction (PCR) was used to characterize the carriage of HLA-DRB1*11 and 1*12 alleles. The HLA-DRB1*11 allele was present in 26.59% of cases and 22.55% of controls. The HLA-DRB1*12 allele was present in 56.63% of cases and 55.88% of controls. This study found no direct association between the carriage of the HLA-DRB1*11 and HLA-DRB1*12 alleles and the occurrence of breast cancer. In addition, the deletion of the HLA-DRB1*11 allele is associated (beneficial effect) with obesity/overweight (OR = 0.13; 95% CI [0.01–1.14]; and p = 0.03) which is a risk for breast cancer. No direct association was found between the carriage of HLA-DRB1*11 and 1*12 alleles and breast cancer risk. However, further investigation of other HLA alleles involved in the occurrence of breast cancer may provide more information.Zouré Abdou AzaqueAmegnona Lanyo JospinZongo NayiKiendrebeogo Isabelle TouwendpoulimdéSorgho Pegdwendé AbelZongo Fabienne IngridYonli Albert ThéophaneSombié Herman KarimBambara Aboubacar HierrhumSawadogo Alexis YobiOuedraogo Marie N. L.Traoré LassinaZongo Sidnooma VéroniqueLallogo Doriane TatianaBazié Bapio Valery Jean Télesphore ElviraZohoncon Théodora M.Dijgma Florencia W.Simpore JacquesDe Gruyterarticlebreast cancerhla-drb1*11hla-drb1*12risk factorsburkina fasoBiology (General)QH301-705.5ENOpen Life Sciences, Vol 16, Iss 1, Pp 1101-1110 (2021)
institution DOAJ
collection DOAJ
language EN
topic breast cancer
hla-drb1*11
hla-drb1*12
risk factors
burkina faso
Biology (General)
QH301-705.5
spellingShingle breast cancer
hla-drb1*11
hla-drb1*12
risk factors
burkina faso
Biology (General)
QH301-705.5
Zouré Abdou Azaque
Amegnona Lanyo Jospin
Zongo Nayi
Kiendrebeogo Isabelle Touwendpoulimdé
Sorgho Pegdwendé Abel
Zongo Fabienne Ingrid
Yonli Albert Théophane
Sombié Herman Karim
Bambara Aboubacar Hierrhum
Sawadogo Alexis Yobi
Ouedraogo Marie N. L.
Traoré Lassina
Zongo Sidnooma Véronique
Lallogo Doriane Tatiana
Bazié Bapio Valery Jean Télesphore Elvira
Zohoncon Théodora M.
Dijgma Florencia W.
Simpore Jacques
Carriage of HLA-DRB1*11 and 1*12 alleles and risk factors in patients with breast cancer in Burkina Faso
description Several factors contribute to the development of breast cancer, including the immune system. This study is aimed to characterize the carriage of human leukocyte antigen (HLA)-DRB1*11 and 1*12 alleles in patients with breast cancer. This case-control study consisted of 96 histologically diagnosed breast cancer cases and 102 controls (cases without breast abnormalities). A multiplex polymerase chain reaction (PCR) was used to characterize the carriage of HLA-DRB1*11 and 1*12 alleles. The HLA-DRB1*11 allele was present in 26.59% of cases and 22.55% of controls. The HLA-DRB1*12 allele was present in 56.63% of cases and 55.88% of controls. This study found no direct association between the carriage of the HLA-DRB1*11 and HLA-DRB1*12 alleles and the occurrence of breast cancer. In addition, the deletion of the HLA-DRB1*11 allele is associated (beneficial effect) with obesity/overweight (OR = 0.13; 95% CI [0.01–1.14]; and p = 0.03) which is a risk for breast cancer. No direct association was found between the carriage of HLA-DRB1*11 and 1*12 alleles and breast cancer risk. However, further investigation of other HLA alleles involved in the occurrence of breast cancer may provide more information.
format article
author Zouré Abdou Azaque
Amegnona Lanyo Jospin
Zongo Nayi
Kiendrebeogo Isabelle Touwendpoulimdé
Sorgho Pegdwendé Abel
Zongo Fabienne Ingrid
Yonli Albert Théophane
Sombié Herman Karim
Bambara Aboubacar Hierrhum
Sawadogo Alexis Yobi
Ouedraogo Marie N. L.
Traoré Lassina
Zongo Sidnooma Véronique
Lallogo Doriane Tatiana
Bazié Bapio Valery Jean Télesphore Elvira
Zohoncon Théodora M.
Dijgma Florencia W.
Simpore Jacques
author_facet Zouré Abdou Azaque
Amegnona Lanyo Jospin
Zongo Nayi
Kiendrebeogo Isabelle Touwendpoulimdé
Sorgho Pegdwendé Abel
Zongo Fabienne Ingrid
Yonli Albert Théophane
Sombié Herman Karim
Bambara Aboubacar Hierrhum
Sawadogo Alexis Yobi
Ouedraogo Marie N. L.
Traoré Lassina
Zongo Sidnooma Véronique
Lallogo Doriane Tatiana
Bazié Bapio Valery Jean Télesphore Elvira
Zohoncon Théodora M.
Dijgma Florencia W.
Simpore Jacques
author_sort Zouré Abdou Azaque
title Carriage of HLA-DRB1*11 and 1*12 alleles and risk factors in patients with breast cancer in Burkina Faso
title_short Carriage of HLA-DRB1*11 and 1*12 alleles and risk factors in patients with breast cancer in Burkina Faso
title_full Carriage of HLA-DRB1*11 and 1*12 alleles and risk factors in patients with breast cancer in Burkina Faso
title_fullStr Carriage of HLA-DRB1*11 and 1*12 alleles and risk factors in patients with breast cancer in Burkina Faso
title_full_unstemmed Carriage of HLA-DRB1*11 and 1*12 alleles and risk factors in patients with breast cancer in Burkina Faso
title_sort carriage of hla-drb1*11 and 1*12 alleles and risk factors in patients with breast cancer in burkina faso
publisher De Gruyter
publishDate 2021
url https://doaj.org/article/7114d3260cc844129f4e9785dec6afb8
work_keys_str_mv AT zoureabdouazaque carriageofhladrb111and112allelesandriskfactorsinpatientswithbreastcancerinburkinafaso
AT amegnonalanyojospin carriageofhladrb111and112allelesandriskfactorsinpatientswithbreastcancerinburkinafaso
AT zongonayi carriageofhladrb111and112allelesandriskfactorsinpatientswithbreastcancerinburkinafaso
AT kiendrebeogoisabelletouwendpoulimde carriageofhladrb111and112allelesandriskfactorsinpatientswithbreastcancerinburkinafaso
AT sorghopegdwendeabel carriageofhladrb111and112allelesandriskfactorsinpatientswithbreastcancerinburkinafaso
AT zongofabienneingrid carriageofhladrb111and112allelesandriskfactorsinpatientswithbreastcancerinburkinafaso
AT yonlialberttheophane carriageofhladrb111and112allelesandriskfactorsinpatientswithbreastcancerinburkinafaso
AT sombiehermankarim carriageofhladrb111and112allelesandriskfactorsinpatientswithbreastcancerinburkinafaso
AT bambaraaboubacarhierrhum carriageofhladrb111and112allelesandriskfactorsinpatientswithbreastcancerinburkinafaso
AT sawadogoalexisyobi carriageofhladrb111and112allelesandriskfactorsinpatientswithbreastcancerinburkinafaso
AT ouedraogomarienl carriageofhladrb111and112allelesandriskfactorsinpatientswithbreastcancerinburkinafaso
AT traorelassina carriageofhladrb111and112allelesandriskfactorsinpatientswithbreastcancerinburkinafaso
AT zongosidnoomaveronique carriageofhladrb111and112allelesandriskfactorsinpatientswithbreastcancerinburkinafaso
AT lallogodorianetatiana carriageofhladrb111and112allelesandriskfactorsinpatientswithbreastcancerinburkinafaso
AT baziebapiovaleryjeantelesphoreelvira carriageofhladrb111and112allelesandriskfactorsinpatientswithbreastcancerinburkinafaso
AT zohoncontheodoram carriageofhladrb111and112allelesandriskfactorsinpatientswithbreastcancerinburkinafaso
AT dijgmaflorenciaw carriageofhladrb111and112allelesandriskfactorsinpatientswithbreastcancerinburkinafaso
AT simporejacques carriageofhladrb111and112allelesandriskfactorsinpatientswithbreastcancerinburkinafaso
_version_ 1718371792013230080